Despite improvements in neuroblastoma treatment, survival figures lag behind those of many other childhood malignancies. New ...
Journal of Nuclear Medicine February 2025, jnumed.124.268612; DOI: https://doi.org/10.2967/jnumed.124.268612 A key challenge in advancing RPTs is variability in AD ...
Journal of Nuclear Medicine February 2025, jnumed.124.268079; DOI: https://doi.org/10.2967/jnumed.124.268079 ...
Journal of Nuclear Medicine February 2025, jnumed.124.268640; DOI: https://doi.org/10.2967/jnumed.124.268640 ...
Journal of Nuclear Medicine February 2025, jnumed.124.268762; DOI: https://doi.org/10.2967/jnumed.124.268762 ...
Journal of Nuclear Medicine February 2025, jnumed.124.268586; DOI: https://doi.org/10.2967/jnumed.124.268586 ...
Journal of Nuclear Medicine February 2025, jnumed.124.269024; DOI: https://doi.org/10.2967/jnumed.124.269024 ...
Radiopharmaceutical therapy (RPT), with its targeted delivery of cytotoxic ionizing radiation, demonstrates significant potential for treating a wide spectrum of malignancies, with particularly unique ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
Journal of Nuclear Medicine February 2025, jnumed.124.267809; DOI: https://doi.org/10.2967/jnumed.124.267809 ...